Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data

Size: px
Start display at page:

Download "Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data"

Transcription

1 Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data Quan Chen, Eric Tai, Shayne Gallaway, Sherri L. Stewart, Thomas Tucker, Jaclyn Nee, Bin Huang 2018 NAACCR June 14 Pittsburgh, PA

2 Background Cigarette smoking status is an important factor for population-based cancer outcome research. Smoking causes cancers of the lung, pancreas, colon, and rectum etc. In 2011, 221,130 new cases of lung cancer occurred, 90% of which were attributable to smoking Smoking not only cause cancers, but is also associated with comorbidity status and survival for cancer patients. COPD, heart disease, stroke, TB. Due to limited resources, smoking history is either not well captured or not at all in population-based cancer registry data.

3 Background Cont. Kentucky Cancer Registry (KCR) data linkage projects Link KCR ( ) with claims from SEER*Medicare( ), Medicaid( ), private insurance groups( ) Probabilistic linkage and manual review Six cancer types: Lung, Colorectal, Breast, Pancreatic, Ovary, and Prostate Augmenting results: Treatments: Chemotherapy, Radiotherapy, Hormone therapy; Comorbidities Smoking History

4 Research Aim Examining the feasibility to augment smoking history in the registry data with health administrative claims Examining the prevalence of smoking and smoking cessation among tobacco related cancers (TRC) and non tobacco related cancers (ntrc) TRC: Lung, Colorectal, and Pancreatic ntrc: Breast, Ovary, and Prostate

5 Methods Linked Kentucky cancer cases diagnosed in were included in this study. Smoking history in KCR data were captured as Cigarette Pack Years Tobacco history 0 Never used Non-Smoker 1 Cigarette smoker 2 Cigar/pipe smoker 3 Snuff/chew/smokeless tobacco user 4 Mixed use of more than one type of tobacco product Smoker 5 E-cigarettes 6 E-cigarettes plus another type of tobacco product 9 Not recorded/unknown Unknown

6 Methods Cont. Smoking history in Claims data was calculated by identifying ICD and CPT codes of personal history of tobacco use or disorder, and smoking cessation and counseling HCPCS/CPT: G0436 G0437 G0375 G0376 S9075 S9453 ICD: x V15.82

7 Methods Cont. The following algorithm was used to augment the smoking history in KCR : Limited the claims within 12 months before cancer diagnosis. If smoking history in KCR was either Non Smoker or Unknown, and claims captured smoking history information, then KCR data was augmented as Smoker. Smoking cessation (counseling or pharmacotherapy) were captured based on claims within 12 months before or 12 months after cancer diagnosis. Nicotine replacement therapy (NRT) Bupropion (Zyban, Wellbutrin ) Varenicline (Chantix )

8 Results- Smoking History for TRC Cancer Type # of Patient s KCR Smoker Claims Smoker Both Sources Augmented Data N % N % N % N % TRC Lung Colorect al Pancrea s % % % % % % % % % % % % % % % %

9 Results- Smoking History for ntrc Cancer Type # of Patient s KCR Smoker Claims Smoker Both Sources Augmented Data N % N % N % N % NTRC Breast Ovary Prostate % % % % % % % % % % % % % % % %

10 Results - % Extra smokers captured by health claims data 30% 23% 21% 15% 15% 8% 10% 8% 11% 10% 8% 12% 0% TRC Colorectal NTRC Ovary

11 Results - Smoking cessation counseling usage identified through claims Cancer Smokers identifie d in Claims Pre-Dx Post-Dx Pre and Post - Dx N % N % N % N % TRC % % % % Lung % % % % Colorecta 2.14% 2 l % 0.24% % Pancreas % % % % N-TRC % % % % Breast % % % % Ovary % % % % Prostate % % % % All

12 Results - Smoking related pharmacotherapy usage identified through claims Cancer Smokers identifie d in Claims Pre-Dx Post-Dx Pre and Post - Dx All N % N % N % N % TRC % % % % Lung % % % % Colorecta % 5.69% l % % 48 Pancreas % % % % NTRC % % % % Breast % % % % Ovary % % % % Prostate % % % %

13 Global Moran's I Spatial Autocorrelation High-High Counties with high smoking prevalence surrounded by counties with high smoking prevalence High-Low Low-High Low-Low

14 Summary Health administrative claims data are good sources to improve cancer registry data on smoking history. Smoking history information have been augmented about 10% for both TRC and ntrc patients. Comparing to ntrc, TRC patients were more likely to have history of smoking (64.3% vs. 40.0%) although the differences mainly come from lung cancer.

15 Summary Cont. The large percentages of smokers in ntrc reflects the high smoker rates in the background population BRFSS- KY 29% smoking rate, 1 st in US In Kentucky, only 6.4% of lung cancer patients had post diagnosis smoking cessation counseling and 4.5% of them received pharmacotherapy. Studies have found that tobacco cessation usage among lung cancer patients after diagnosis may increase overall survival by 9 months.

16 Acknowledgement Funding Support: CDC U48DP SIP NCI SEER HHSN

17 Thank you! Quan Chen, University of Kentucky

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky

Faculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative

More information

Utilization of OncoType DX Test for

Utilization of OncoType DX Test for Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy

More information

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2006 The Kentucky Department for Public Health University of Kentucky College of Nursing Local Tobacco Cessation Survey, 2006 Health Department Report prepared through a contract between the Kentucky Cabinet

More information

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today

Slide 1. Slide 2. Slide 3. Reducing Tobacco Use and Nicotine Dependence in Clinical Settings. Goals for Today Slide 1 UNIVERSITY OF HAWAI I CANCER CENTER Reducing Tobacco Use and Nicotine Dependence in Clinical Settings Pebbles Fagan, Ph.D., M.P.H. Associate Professor and Program Director Cancer Prevention and

More information

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007

The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007 The Kentucky Department for Public Health University of Kentucky College of Nursing Local Health Department Tobacco Cessation Survey, 2007 District Health Department Report prepared through a contract

More information

A New Measure to Assess the Completeness of Case Ascertainment

A New Measure to Assess the Completeness of Case Ascertainment A New Measure to Assess the Completeness of Case Ascertainment Barnali Das, Ph.D. Linda Pickle, Ph.D. Eric J. (Rocky) Feuer, Ph.D. Lin Clegg, Ph.D. Surveillance Research Program, National Cancer Institute

More information

Potentially preventable cancers among Alaska Native people

Potentially preventable cancers among Alaska Native people Potentially preventable cancers among Alaska Native people Sarah Nash Cancer Surveillance Director, Alaska Native Tumor Registry Diana Redwood, Ellen Provost Alaska Native Epidemiology Center Cancer is

More information

Tobacco Use Dependence and Approaches to Treatment

Tobacco Use Dependence and Approaches to Treatment University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo

More information

Best Practices in Tobacco Treatment IDN

Best Practices in Tobacco Treatment IDN Best Practices in Tobacco Treatment IDN 6.27.18 Objectives Project SCUM was a plan proposed in 1995 by R. J. Reynolds Tobacco Company (RJR) to sell cigarettes to members of the "alternative lifestyle"

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 4005-2 Program Health Care Reform Tobacco Cessation Supply Limit (Therapy Duration) Override Kentucky Fully Insured Medication

More information

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits

Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits Technical Assistance Tool October 2017 Sample Managed Care Organization Survey Questions to Assess Smoking Prevalence and Available Cessation Benefits C ross-agency Medicaid-Public Health teams interested

More information

Helping Employees Break the Habit

Helping Employees Break the Habit Helping Employees Break the Habit May 28, 2014 Diane Andrea, RD, LD Wellness Consultant Surgeon General s Report on Smoking and Health 1964 Report first issued, 42% of Americans smoke 1966 Required warning

More information

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use

Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use Measure #114: Preventive Care and Screening: Inquiry Regarding Tobacco Use 2010 PQRI REPTING OPTIONS F INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage of patients aged 18 years or older who

More information

Smoking Cessation Strategies: What Works?

Smoking Cessation Strategies: What Works? Smoking Cessation Strategies: What Works? Andrew M. Busch, Ph.D. Centers For Behavioral and Preventive Medicine The Miriam Hospital Department of Psychiatry and Human Behavior Alpert Medical School of

More information

Health Promotion, Screening, & Early Detection

Health Promotion, Screening, & Early Detection OCN Test Content Outline 2018 Health Promotion, Screening, & Early Detection Kelley Blake MSN, RN, AOCNS, OCN UW Medicine/Valley Medical Center I. Care Continuum 19% A. Health promotion & disease prevention

More information

CANCER FACTS & FIGURES For African Americans

CANCER FACTS & FIGURES For African Americans CANCER FACTS & FIGURES For African Americans Pennsylvania, 2006 Pennsylvania Cancer Registry Bureau of Health Statistics and Research Contents Data Hightlights...1 Pennsylvania and U.S. Comparison...5

More information

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

How to help your patient quit smoking. Christopher M. Johnson MD, PhD How to help your patient quit smoking Christopher M. Johnson MD, PhD Outline Smoking and its effects on IBD CD UC Clinical interventions Pharmacotherapy Resources Outline Smoking and its effects on IBD

More information

Introduction to pharmacotherapy

Introduction to pharmacotherapy Introduction to pharmacotherapy Dr. Shamim Jubayer. Research Fellow Dept. Epidemiology and Research National Heart Foundation Hospital And research Institute Effective tobacco cessation medications The

More information

Management of Perinatal Tobacco Use

Management of Perinatal Tobacco Use Management of Perinatal Tobacco Use David Stamilio, MD, MSCE Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, UNC School of Medicine Funding for this project is provided in

More information

Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017

Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017 Presentation Overview Background Methods Results Conclusions 2 1 Background Increase physician reporting Capture missing first course treatment Capture

More information

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with

More information

Welcome ACoS Brainstorming Webinar

Welcome ACoS Brainstorming Webinar Welcome ACoS Brainstorming Webinar Dr. Youjie Huang DOH CER PI Dr. Jill MacKinnon FCDS Project Director Dr. Monique Hernandez FCDS CER Project Manager Mike Thiry FCDS Manager for Data Acquisition Steve

More information

CERCIT Workshop: Texas Cancer Registry; Medicaid; Registry Linked Claims Data

CERCIT Workshop: Texas Cancer Registry; Medicaid; Registry Linked Claims Data CERCIT Workshop: About the Data: Texas Cancer Registry; Medicaid; Registry Linked Claims Data MelanieWilliams,PhD,Manager, Texas Cancer Registry Melanie Williams, PhD, Manager, Texas Cancer Registry Cheryl

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of

More information

Leveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky

Leveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky Leveraging Electronic Pathology Reporting in Cervical Cancer Epidemiology: Determinants of Invasive Diagnoses in Kentucky Presented by: Eric B. Durbin, DrPH, MS Director of Cancer Informatics Kentucky

More information

Adolescents and Tobacco Cessation

Adolescents and Tobacco Cessation Adolescents and Tobacco Cessation Jonathan D. Klein, MD, MPH American Academy of Pediatrics Julius B. Richmond Center and the University of Rochester Rochester, NY Goal To review current evidence and perspectives

More information

Sociodemographic and Clinical Predictors of Triple Negative Breast Cancer

Sociodemographic and Clinical Predictors of Triple Negative Breast Cancer University of Kentucky UKnowledge Theses and Dissertations--Public Health (M.P.H. & Dr.P.H.) College of Public Health 2017 Sociodemographic and Clinical Predictors of Triple Negative Breast Cancer Madison

More information

Nicotine Replacement and Smoking Cessation: Update on Best Practices

Nicotine Replacement and Smoking Cessation: Update on Best Practices Nicotine Replacement and Smoking Cessation: Update on Best Practices Adrienne Duckworth, MSN, APRN, FNP-C, CTTS Section of Hematology/Oncology WVU Department of Medicine WVU Cancer Institute Objective

More information

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation

Smoking Cessation. MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Smoking Cessation MariBeth Kuntz, PA-C Duke Center for Smoking Cessation Objectives Tobacco use at population level Tobacco use and control around the world What works for managing tobacco use Common myths

More information

Making Your Business Tobacco Free

Making Your Business Tobacco Free Making Your Business Tobacco Free May 19, 2016 Adrienne Rollins, MPA CPS Tobacco Use Prevention Manager Oklahoma State Department of Health Objectives: Tobacco-Free Policy Good for Business Participants

More information

Classes and Quitlines and Patches, Oh My! Tobacco Use Why it is Your Business. Deirdre Sullivan, Health Educator

Classes and Quitlines and Patches, Oh My! Tobacco Use Why it is Your Business. Deirdre Sullivan, Health Educator Classes and Quitlines and Patches, Oh My! Tobacco Use Why it is Your Business Deirdre Sullivan, Health Educator Why Tobacco? Smoking is the leading cause of preventable death and disability in the United

More information

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting Eric B. Durbin, DrPH, MS, Director of Cancer Informatics Frances E. Ross, CTR,

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table

More information

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for

More information

Smoking Cessation: Treating Tobacco Dependence

Smoking Cessation: Treating Tobacco Dependence Smoking Cessation: Treating Tobacco Dependence Pat Folan, RN Center for Tobacco Control Pulmonary Medicine NS-LIJ Health System NYS DOH Tobacco Control Program Treating Tobacco Dependence Center for Tobacco

More information

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare

Tobacco Cessation: Best Practices in Cancer Treatment. Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Tobacco Cessation: Best Practices in Cancer Treatment Audrey Darville, PhD APRN, CTTS Certified Tobacco Treatment Specialist UKHealthCare Objectives 1. Describe the current state of tobacco use treatment

More information

2014 Oncology Measures Group Overview

2014 Oncology Measures Group Overview 2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:

More information

7/29/2014. FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida

7/29/2014. FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida FCDS Annual Meeting July 24-25, 2014 Caribe Royale Resort Orlando, Florida Data collected by central cancer registries is utilized for patient outcomes research Requires complete detailed treatment data

More information

BILLING GUIDE FOR TOBACCO SCREENING AND CESSATION

BILLING GUIDE FOR TOBACCO SCREENING AND CESSATION Tobacco use status is now embedded in most of the major electronic health records and evidence-based tobacco cessation counseling and pharmacotherapy covered by Medicare, Medicaid and most private health

More information

Quitting smoking is hard

Quitting smoking is hard Quitting smoking is hard About 2 out of 3 of smokers say they want to quit About half try to quit each year, but few succeed without help Smokers become physically dependent on nicotine, but there s also

More information

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is

More information

Annual Report. Kentucky Cancer Registry. Includes a Special Report: Colorectal Cancer in Kentucky

Annual Report. Kentucky Cancer Registry. Includes a Special Report: Colorectal Cancer in Kentucky Kentucky Cancer Registry December 2008 Annual Report Cancer Incidence and Mortality in Kentucky, 2001-2005 Includes a Special Report: Colorectal Cancer in Kentucky ACKNOWLEDGEMENTS The population-based

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 2045-9 Program Prior Authorization/HCR- Tobacco Cessation - Health Care Reform Medication Bupropion SR (generic Zyban), Chantix

More information

RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits

RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits RI Health Plan 2018 Annual Report Form on Tobacco Cessation Benefits Purpose: To collect data from each health plans fully insured accounts for policies issued in RI to insured members regardless of where

More information

What is Quitline Iowa?

What is Quitline Iowa? CONTENTS: What is Quitline Iowa? 0 A telephone counseling helpline for tobacco-use cessation. Free to all residents of the state of Iowa Open Monday-Thursday 7:00am 12:00am / Friday 7:00am 9:00pm / Saturday

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing

Tobacco Dependence Screening and Treatment in Behavioral Health Settings. Prescribing Tobacco Dependence Screening and Treatment in Behavioral Health Settings Prescribing GOAL To build the capacity of prescribing clinicians in behavioral health settings to integrate best practices for prescribing

More information

Evaluation of the Workplace-based Quit Smoking Programs. Intake Survey

Evaluation of the Workplace-based Quit Smoking Programs. Intake Survey Evaluation of the Workplace-based Quit Smoking Programs Intake Survey Information about You and Your Smoking Please check your answer or write your answer in the spaces provided. PLEASE COMPLETE - Your

More information

Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals

Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals Summary of Cancer Prevention and Screening Benefits of the Affordable Care Act (ACA) in Kentucky for health professionals Talk with patients about ü Cancer Prevention & Early Detection ü Benefits, harms

More information

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer

Criteria USPSTF CMS. Frequency Annual screening Annual screening. No signs or symptoms of lung cancer Lung Cancer Screening Guidelines with low- dose computed tomography (LDCT): USPSTF and CMS February 6, 2015 Kentucky Cancer Consortium and Kentucky LEADS Component 3 Jennifer Redmond Knight, DrPH, jredknight@kycancerc.org

More information

Tobacco Control Highlights Wisconsin

Tobacco Control Highlights Wisconsin Tobacco Control Highlights Wisconsin Health Consequences and Costs Smoking - Attributable Mortality (SAM), 2000-2004 Smoking - Attributable Productivity Losses, 2000-2004 Smoking - Attributable Expenditures

More information

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD

PANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.

More information

Tobacco Control Highlights Alaska

Tobacco Control Highlights Alaska Tobacco Control Highlights Alaska Health Consequences and Costs Smoking - Attributable Mortality (SAM), 2000-2004 Smoking - Attributable Productivity Losses, 2000-2004 Smoking - Attributable Expenditures

More information

Effective Treatments for Tobacco Dependence

Effective Treatments for Tobacco Dependence Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for

More information

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people* What is the Impact of Cancer on African Americans in Indiana? Table 13. Burden of Cancer among African Americans Indiana, 2008 2012 Average number of cases per year Rate per 100,000 people* Number of cases

More information

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA

HIV and Aging. Making Tobacco Cessation a Priority in HIV/AIDS Services. Objectives. Tobacco Use Among PLWHA HIV and Aging Making Tobacco Cessation a Priority in HIV/AIDS Services June 27, 2008 Amanda Brown, MPH Ruth Tripp, MPH, RN Objectives To explore existing knowledge of the HIV and smoking connection. To

More information

Advancing Health Equity in Lung Cancer Outcomes

Advancing Health Equity in Lung Cancer Outcomes Advancing Health Equity in Lung Cancer Outcomes Edwin J Jackson Jr. DO Pulmonary and Critical Care Medicine Disclosures Funding: American Thoracic Society 2 1 Lecture Outline Cancer Disparities Smoking

More information

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence

Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence Truman Medical Center-Hospital Hill Cancer Registry 2014 Statistical Summary Incidence In 2014, there were 452 new cancer cases diagnosed and or treated at Truman Medical Center- Hospital Hill and an additional

More information

Smoking Cessation. Samer Kanaan, M.D.

Smoking Cessation. Samer Kanaan, M.D. Smoking Cessation Samer Kanaan, M.D. Goals Understand the Societal impact of Smoking Smoking Cessation: The 5 A Model - Ask, Advise, Assess, Assist, Arrange Review The Stages of Change Review smoking cessation

More information

Cessation Medicine Reference Guide Table of Contents

Cessation Medicine Reference Guide Table of Contents Cessation Medicine Reference Guide Table of Contents 1. Patch 2. Nicotine Gum 3. Nicotine Lozenge 4. Inhaler 5. Nasal Spray 6. Bupropion SR (Zyban) 7. Chantix (Varenicline) Patch Typical course of therapy

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2045-6 Program Prior Authorization/HCR- Tobacco Cessation - Health Care Reform Medication Bupropion SR (generic Zyban), Chantix

More information

Development, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention

Development, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention Development, Implementation, and Dissemination of the Nurse-Administered Tobacco Tactics Intervention Sonia A. Duffy, PhD, RN, FAAN The Ohio State University, College of Nursing and the VA Ann Arbor Healthcare

More information

Total Health Quality Indicators For Providers 2017

Total Health Quality Indicators For Providers 2017 Well Adult Well Visit 20 yrs > Yearly 99385-87, 99395-97, G0402, G0438, G0439, G0463 Total Health Quality Indicators For Providers 2017 Adult- Preventive Z00.00 Report ALL components of an annual visit

More information

Decoding the USPSTF. By: Dr Vikram Arora Heritage Valley Health System

Decoding the USPSTF. By: Dr Vikram Arora Heritage Valley Health System Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System Objectives O Gain insight into function of USPSTF O Review grading system O Critically appraise key current recommendations of the

More information

Trends in electronic cigarette use in England

Trends in electronic cigarette use in England Trends in electronic cigarette use in England Robert West Jamie Brown Emma Beard University College London Updated 14 th April 215 Background Electronic cigarette use has become prevalent in many countries

More information

Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018

Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018 Cancer in Maine: Using Data to Direct Actions 2018 Challenge Cancer Conference May 1, 2018 Tim Cowan, MSPH Director, Data Reporting and Evaluation Center for Health Improvement MaineHealth All Cancer Mortality

More information

TO ONE S SELF, OTHERS,& ENVIRONMENT

TO ONE S SELF, OTHERS,& ENVIRONMENT SMOKING IS A HEALTH DESTRUCTIVE HABIT TO ONE S SELF, OTHERS,& ENVIRONMENT EVERY SMOKER SHOULD BE OFFERED TREATMENT TO QUIT Juliette Jibrail Juliette Jibrail Nov. 11, 2007 Thorough Internet Search Variety

More information

The Science and Practice of Perinatal Tobacco Use Cessation

The Science and Practice of Perinatal Tobacco Use Cessation 1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure

More information

Background. Abstinence rates associated with varenicline

Background. Abstinence rates associated with varenicline What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) Derbyshire Formulary for Nicotine Replacement Therapy (NRT) 1. Supporting Smokers to stop smoking The most effective method to quit smoking is by quitting

More information

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019

Medication Management to Aid in Smoking Cessation. Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 Medication Management to Aid in Smoking Cessation Rachel Constant, Pharm.D. Baptist Health Corbin Pharmacy Resident 3/22/2019 1 Learning Objectives: Review the prevalence of tobacco use. Describe tools

More information

Pharmacotherapy for Tobacco Dependence Treatment

Pharmacotherapy for Tobacco Dependence Treatment Pharmacotherapy for Tobacco Dependence Treatment Nancy Rigotti, MD Professor of Medicine, Harvard Medical School Director, Tobacco Research and Treatment Center, Massachusetts General Hospital nrigotti@partners.org

More information

Treating Tobacco Use and Dependence

Treating Tobacco Use and Dependence Treating Tobacco Use and Dependence October 26, 2017 Great Plains Quality Improvement Network 1 Treating Tobacco Use and Dependence: Agenda Brief history and developmental process Facts about Tobacco Clinical

More information

Tobacco Dependence Treatment: A Resource Guide. Last Update: 06/2013

Tobacco Dependence Treatment: A Resource Guide. Last Update: 06/2013 Tobacco Dependence Treatment: A Resource Guide Last Update: 06/2013 1 Nicotine Replacement Therapy, combined with some form of social support or coaching can double, triple, or even quadruple your chances

More information

Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings

Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings Strategies for Integrating Smoking Cessation & Wellness into Psychiatric & Substance Abuse Treatment Settings Antoine Douaihy, MD Associate Professor of Psychiatry University of Pittsburgh School of Medicine

More information

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

PHARMACOTHERAPY OF SMOKING CESSATION

PHARMACOTHERAPY OF SMOKING CESSATION PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure

More information

8/26/17. Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery. Cancer in the United States

8/26/17. Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery. Cancer in the United States Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery Cancer in the United States CDC and ASCO: Cancer leading cause of death in 22 states In 2033:

More information

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties

More information

Smoking Cessation: A readily modifiable risk factor

Smoking Cessation: A readily modifiable risk factor Robert L. Keith MD FCCP Associate Professor of Medicine Medical Director of Respiratory Therapy Eastern Colorado Health Care System University of Colorado Denver Smoking Cessation: A readily modifiable

More information

Annual Tobacco Report 2000

Annual Tobacco Report 2000 Louisiana Tobacco Control Program Annual Tobacco Report 2000 This report summarizes indicators of tobacco use among adults, pregnant women, and youth in the state of Louisiana, and is set to serve as a

More information

Common Questions about Cancer

Common Questions about Cancer 6 What is cancer? Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. The cancer cells form tumors that destroy normal tissue. If cancer cells break away from

More information

American Vaping Association

American Vaping Association Vaping.info American Vaping Association Gregory Conley, J.D., M.BA. President American Vaping Association Research Fellow Heartland Institute Member -- Gregory Conley Consulting, LLC Twitter: @GregTHR

More information

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures

Disclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional

More information

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in

More information

Drug Use Evaluation: Smoking Cessation

Drug Use Evaluation: Smoking Cessation Drug Use Research & Management Program Oregon State University, 3303 SW Bond Av CH12C, Portland, Oregon 97239-4501 Phone 503-947-5220 Fax 503-494-1082 Drug Use Evaluation: Smoking Cessation Tobacco cessation

More information

The Kentucky Department for Public Health University of Kentucky College of Nursing Knox County Health Department Tobacco Cessation Survey, 2001

The Kentucky Department for Public Health University of Kentucky College of Nursing Knox County Health Department Tobacco Cessation Survey, 2001 1. Are you or other health department staff involved in providing tobacco cessation programs? 2. If, what programs do you provide? a. Fresh Start (American Cancer Society) b. Freedom from Smoking (American

More information

UAMS Tobacco and Disease Symposium 2018 Session 2 Documentation and Coding for Tobacco Cessation Assessment and Counseling.

UAMS Tobacco and Disease Symposium 2018 Session 2 Documentation and Coding for Tobacco Cessation Assessment and Counseling. UAMS Tobacco and Disease Symposium 2018 Session 2 Documentation and Coding for Tobacco Cessation Assessment and Counseling November 16, 2018 Today s Presenter Gail Olin, MSHI, MSN, RN, CPHQ, CPC, CHSRAP

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process Measure #226 (NQF 0028): Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention National Quality Strategy Domain: Community / Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Ian Landry, MPH Beth Schmidt, MSPH

Ian Landry, MPH Beth Schmidt, MSPH Mary Charlton, PhD Bobbi Matt, CTR Mary Anne Lynch, MPH Vivien Chen, PhD Ian Landry, MPH Beth Schmidt, MSPH Response to EGFR inhibitors is poorer among Stage IV colorectal cancer (CRC) patients with KRAS

More information

M C acomb ounty Tobacco Treatment Toolkit. for Physicians

M C acomb ounty Tobacco Treatment Toolkit. for Physicians M C acomb ounty Tobacco Treatment Toolkit for Physicians 43525 Elizabeth Rd. Mt. Clemens, MI 48043-1078 (586) 469-5373 www.macombtobaccoprevention.com Dear Physician/Clinician, The tobacco epidemic is

More information

Tobacco Cessation & Living Tobacco-Free After Cancer. Linda Hancock, FNP, PhD VCU Wellness Resource Center

Tobacco Cessation & Living Tobacco-Free After Cancer. Linda Hancock, FNP, PhD VCU Wellness Resource Center Tobacco Cessation & Living Tobacco-Free After Cancer Linda Hancock, FNP, PhD VCU Wellness Resource Center Introductions Clickers to poll the room and find out something about the people who attended but

More information

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes

More information

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA (515) Fax IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road Des Moines, IA 50315 (515) 974-3131 Fax 1-866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Mark Graber, M.D.,

More information

Pharmacologic Therapy for Tobacco Use & Dependence

Pharmacologic Therapy for Tobacco Use & Dependence Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications

More information

ECHO Clinics. Schedule and Curriculum Topics. Tuesdays 12:00 1:00 pm. Date Topic Presenter. Cessation: An Overview Part 2

ECHO Clinics. Schedule and Curriculum Topics. Tuesdays 12:00 1:00 pm. Date Topic Presenter. Cessation: An Overview Part 2 ECHO Clinics Schedule and Curriculum Topics Tuesdays 12:00 1:00 pm Date Topic Presenter Tuesday, September 19, 2017 Cessation: An Overview Part 1 Tuesday, September 26, 2017 Neurobiology of Nicotine Dependence

More information

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization

More information